(Q34987424)

5 August 2017

1 reference

title

A potential role of macrophage activation in the treatment of cancer (English)

1 reference

5 August 2017

1 reference

Klimp AH

1

1 reference

5 August 2017

de Vries EG

series ordinal

2

1 reference

5 August 2017

Scherphof GL

series ordinal

3

1 reference

5 August 2017

Daemen T

series ordinal

4

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Critical Reviews in Oncology Hematology

5 August 2017

published in

1 reference

5 August 2017

volume

44

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

143-161

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

5 August 2017

1 reference

7 January 2021

Structure and function of lipopolysaccharide binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Human macrophages respond to LPS in a serum-independent, CD14-dependent manner

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Lipid A and the lipid A analogue anti-tumour compound ONO-4007 induce nitric oxide synthase in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Selective potentiation of cytokine expression in human whole blood by murabutide, a muramyl dipeptide analogue

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Anti-metastatic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

In vivo fate of large unilamellar sphingomyelin-cholesterol liposomes after intraperitoneal and intravenous injection into rats

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Signal transduction pathways in normal human monocytes stimulated by cytokines and mediators: comparative study with normal human neutrophils or transformed cells and the putative roles in functionality and cell biology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumor Necrosis Factor-α and Interferon-γ Modulation of Nitric Oxide and Allograft Survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Cytokines and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

The effects of dose and route of administration on the pharmacokinetics of granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Clinical pharmacokinetic studies of a human haemopoietic growth factor, GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Delivery of cytokines by liposomes. III. Liposome-encapsulated GM-CSF and TNF-alpha show improved pharmacokinetics and biological activity and reduced toxicity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Cytokines in liposomes: preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Expression of intercellular adhesion molecule-1 on macrophages in vitro as a marker of activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Liposome-encapsulated MTP-PE: a novel biologic agent for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Heterogeneity in secretory responses of rat liver macrophages of different size.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Selective induction of CD11a,b,c/CD18 and CD54 expression at the cell surface of human leukocytes by muramyl peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Direct Activation of Murine Peritoneal Macrophages for Nitric Oxide Production and Tumor Cell Killing by Interferon-γ

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Heterogeneity in responses of human blood monocytes to granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Immunomodulation of peritoneal macrophages by granulocyte-macrophage colony-stimulating factor in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Administration of rHuGM-CSF activates monocyte reactive oxygen species secretion and adhesion molecule expression in vivo in patients following high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Granulocyte-macrophage colony-stimulating factor dependent monocyte-mediated cytotoxicity post-autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Monocyte‐mediated killing of human leukaemia is enhanced by administration of granulocyte‐macrophage colony stimulating factor following chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Effect of intraperitoneally administered recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) on the cytotoxic potential of murine peritoneal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Macrophage colony-stimulating factor enhancement of antibody-dependent cellular cytotoxicity against human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Antimetastatic effect of recombinant human macrophage-colony-stimulating factor against lung and liver metastatic B16 melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumoricidal effect of human macrophage-colony-stimulating factor against human-ovarian-carcinoma-bearing athymic mice and its therapeutic effect when combined with cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Enhancement in accessibility to macrophages by modification of mucin-type carbohydrate chains on a tumor cell line: role of a C-type lectin of macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Initial steps in lymph node metastasis formation in an experimental system: possible involvement of recognition by macrophage C-type lectins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Characterization of monocyte-activating tumour cell membrane structures

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Monocyte activation by tumour cells: a role for carbohydrate structures associated with CD2

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Carcinoembryonic antigen binding to Kupffer cells is via a peptide located at the junction of the N-terminal and first loop domains

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Heterogeneous susceptibility of human melanoma clones to monocyte cytotoxicity: role of ICAM-1 defined by antibody blocking and gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Involvement of leukocyte (β2) integrins (CD18/CD11) in human monocyte tumoricidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Suppression of tumor cell susceptibility to monocyte-induced cell death by growth-inhibitory signals generated during monocyte/tumor cell interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Modulation of tumor cell susceptibility to cytokine-induced cell death by hormones, growth factors, and cell density

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Activation of macrophages for ADCC in vitro: Effects of IL-4, TNF, interferons-αβ, interferon-γ, and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Interleukin 1 and tumour necrosis factor alpha may be responsible for the lytic mechanism during anti-tumour antibody-dependent cell-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Membrane form of TNF alpha induces both cell lysis and apoptosis in susceptible target cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFα

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

1 reference

7 January 2021

A novel domain within the 55 kd TNF receptor signals cell death

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

TNF-alpha mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Involvement of a serine protease in tumour-necrosis-factor-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Cytotoxic effect of cytokines on murine colon carcinoma cells involves TNF-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

EPR characterization of molecular targets for NO in mammalian cells and organelles

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Nitric-Oxide Kills Hepatocytes by Mobilizing Mitochondrial Calcium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Nitric oxide is an important mediator for tumoricidal activity in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Role of reactive oxygen metabolites in murine peritoneal macrophage phagocytosis and phagocytic killing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

On the expression of nitric oxide synthase by human macrophages. Why no NO?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Identification of monocyte chemotactic activity produced by malignant cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumor-host interaction: analysis of cytokines, growth factors, and tumor-infiltrating lymphocytes in ovarian carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Mechanism for the recruitment of macrophages to cancer site. In vivo concentration gradient of monocyte chemotactic activity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Anti-colony-stimulating factor-1 antibody staining in primary breast adenocarcinomas correlates with marked inflammatory cell infiltrates and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Regulation of leukocyte binding to endothelial tissues by tumor-derived GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Co-operation between metastatic tumor cells and macrophages in the degradation of basement membrane (type IV) collagen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Differences in angiogenic potential of classically vs alternatively activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Macrophages and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Interleukin-8 as a macrophage-derived mediator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Expression of Angiogenesis-Related Genes and Progression of Human Ovarian Carcinomas in Nude Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Failure to reject an allografted tumor after elimination of macrophages in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumor growth increases Ia- macrophage synthesis of tumor necrosis factor-alpha and prostaglandin E2: changes in macrophage suppressor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Impaired tumoricidal function of alveolar macrophages from patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumoricidal activity of alveolar and peritoneal macrophages of C57BL/6 mice bearing metastatic or nonmetastatic variants of Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Tumoricidal response of liver macrophages isolated from rats bearing liver metastases of colon adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phagocytosis of antigens by Langerhans cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

The mannose receptor and other macrophage lectins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: characterization and evidence for receptor recycling

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Developmental regulation of MHC class II transport in mouse dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha for use in cancer immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phase I trial of intravenous peptide-pulsed dendritic cells in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Human monocyte-derived macrophages and dendritic cells are comparably effective in vitro in presenting HLA class I-restricted exogenous peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phase II study of liposomal muramyl tripeptide in osteosarcoma: the cytokine cascade and monocyte activation following administration

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Anti-tumoral effect of GM-CSF with or without cytokines and monoclonal antibodies in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Adoptive Immunotherapy with Tumor-Cytotoxic Macrophages Derived from Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhuGM-CSF) Mobilized Peripheral Blood Monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phase I/II trial of autologous activated macrophages in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperitoneally to patients with peritoneal carcinomatosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

IL-2 enhances standard IFNgamma/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: a potential for adoptive cellular immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Granulocyte-macrophage-colony stimulating factor in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

A phase I trial of recombinant human macrophage colony-stimulating factor by rapid intravenous infusion in patients with refractory malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte--macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: implications for a clinically relevant tumor vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Demonstration of a rational strategy for human prostate cancer gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

In vivo tumor transfection with superantigen plus cytokine genes induces tumor regression and prolongs survival in dogs with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Angiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Antitumor effect induced by granulocyte/macrophage-colony-stimulating factor gene-modified tumor vaccination: comparison of adenovirus- and retrovirus-mediated genetic transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Active specific immunotherapy of pulmonary metastasis with vaccinia melanoma oncolysate prepared from granulocyte/macrophage-colony-stimulating-factor-gene-encoded vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Genetic modification of a carcinoma with the IL-4 gene increases the influx of dendritic cells relative to other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Activation of peritoneal cells upon in vivo transfection with a recombinant alphavirus expressing GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Enhancement of antitumor immune response in glioma models in mice by genetically modified dendritic cells pulsed with Semliki forest virus-mediated complementary DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1alpha chemokine genes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900203-7

7 January 2021

10.1016/S1040-8428(01)00203-7

Identifiers

DOI

1 reference

5 August 2017

1 reference